Progression-free rate as the principal end-point for phase II trials in soft-tissue sarcomas (Q64112087)
scientific article published on 01 March 2002
Language:
Current Data About Progression-free rate as the principal end-point for phase II trials in soft-tissue sarcomas
(P31) (Q13442814)
(P248)
(P698) 11872347
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11872347%20AND%20SRC:MED&resulttype=core&format=json
(P813) Saturday, December 7, 2019

(Q815382)

(P304) 543-549
(P248)
(P698) 11872347
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11872347%20AND%20SRC:MED&resulttype=core&format=json
(P813) Saturday, December 7, 2019

(P407) (Q1860)

(P433) 4
(P248)
(P698) 11872347
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11872347%20AND%20SRC:MED&resulttype=core&format=json
(P813) Saturday, December 7, 2019

(P478) 38
(P248)
(P698) 11872347
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11872347%20AND%20SRC:MED&resulttype=core&format=json
(P813) Saturday, December 7, 2019

(P577) Friday, March 1, 2002
(P248)
(P698) 11872347
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11872347%20AND%20SRC:MED&resulttype=core&format=json
(P813) Saturday, December 7, 2019

(P921) (Q42824440)
(P887)

(P1433) (Q332260)
(P248)
(P698) 11872347
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11872347%20AND%20SRC:MED&resulttype=core&format=json
(P813) Saturday, December 7, 2019

(P1476) "Progression-free rate as the principal end-point for phase II trials in soft-tissue sarcomas" (language: en)
(P248)
(P698) 11872347
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11872347%20AND%20SRC:MED&resulttype=core&format=json
(P813) Saturday, December 7, 2019

(P2093) M Van Glabbeke
(P1545) 1
(P248)
(P698) 11872347
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11872347%20AND%20SRC:MED&resulttype=core&format=json
(P813) Saturday, December 7, 2019

J Verweij
(P1545) 2
(P248)
(P698) 11872347
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11872347%20AND%20SRC:MED&resulttype=core&format=json
(P813) Saturday, December 7, 2019

I Judson
(P1545) 3
(P248)
(P698) 11872347
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11872347%20AND%20SRC:MED&resulttype=core&format=json
(P813) Saturday, December 7, 2019

O S Nielsen
(P1545) 4
(P248)
(P698) 11872347
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11872347%20AND%20SRC:MED&resulttype=core&format=json
(P813) Saturday, December 7, 2019

EORTC Soft Tissue and Bone Sarcoma Group
(P1545) 5
(P248)
(P698) 11872347
(P854) https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11872347%20AND%20SRC:MED&resulttype=core&format=json
(P813) Saturday, December 7, 2019

(P2860) (Q27860904)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900398-7
(P813) Thursday, January 7, 2021
(P887)

(Q46412217)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900398-7
(P813) Thursday, January 7, 2021
(P887)

(Q70365924)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900398-7
(P813) Thursday, January 7, 2021
(P887)

(Q78846264)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900398-7
(P813) Thursday, January 7, 2021
(P887)

(Q28141331)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900398-7
(P813) Thursday, January 7, 2021
(P887)

(Q67939146)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900398-7
(P813) Thursday, January 7, 2021
(P887)

(Q57571575)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900398-7
(P813) Thursday, January 7, 2021
(P887)

(Q33361664)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900398-7
(P813) Thursday, January 7, 2021
(P887)

(Q33376557)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900398-7
(P813) Thursday, January 7, 2021
(P887)

(Q70534418)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900398-7
(P813) Thursday, January 7, 2021
(P887)

(Q34724640)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900398-7
(P813) Thursday, January 7, 2021
(P887)

(Q57569791)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900398-7
(P813) Thursday, January 7, 2021
(P887)

(Q33379823)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900398-7
(P813) Thursday, January 7, 2021
(P887)

(Q57571606)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900398-7
(P813) Thursday, January 7, 2021
(P887)

(Q34504714)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900398-7
(P813) Thursday, January 7, 2021
(P887)

(Q34042746)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900398-7
(P813) Thursday, January 7, 2021
(P887)

(Q25938997)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900398-7
(P813) Thursday, January 7, 2021
(P887)

(Q60895214)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900398-7
(P813) Thursday, January 7, 2021
(P887)

(Q41123225)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900398-7
(P813) Thursday, January 7, 2021
(P887)

(Q70971469)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900398-7
(P813) Thursday, January 7, 2021
(P887)

(Q72900223)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900398-7
(P813) Thursday, January 7, 2021
(P887)

(Q52890558)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900398-7
(P813) Thursday, January 7, 2021
(P887)

other details
description scientific article published on 01 March 2002

External Links
(P356) 10.1016/S0959-8049(01)00398-7
(P698) 11872347